Horizon 3 Healthcare

Horizon 3 Healthcare is a venture capital firm based in Melbourne, Victoria, Australia, focused on investing in and commercializing promising early-stage human healthcare technologies, particularly within the life sciences and biotechnology sectors. The firm provides capital, board representation, and business development expertise to support the growth of companies developing innovative solutions for therapeutic areas such as infectious diseases, autoimmune conditions, and cancer. Its investment approach draws on the extensive experience of its leadership, including Chief Investment Officer Matt McNamara, who previously oversaw $200 million in funds under management across four funds at BioScience Managers. The team also features Executive Chairman Mike Sullivan and Board Director Jian Sun, founder of Huikang Bio-Tech, contributing to its strategic direction. Horizon 3 Healthcare was co-founded by Mike Sullivan.